The aryl hydrocarbon receptor (AhR) is a cytoplasmic receptor/transcription factor that 18 modulates several cellular and immunological processes following activation by pathogen-19 associated stimuli, though its role during virus infection is largely unknown. Here, we show that 20
replication and the immune response to the virus. 48 49 Introduction 50
Coronaviruses (CoVs) are a group of positive-sense single-stranded RNA viruses 51 responsible for agricultural and human disease with high economic burden and outbreak potential. 52
Understanding the pathways driving CoV replication and pathogenesis is crucial to combat CoVs 53 with high mortality such as severe acute respiratory syndrome (SARS) and Middle East respiratory 54 syndrome (MERS) CoVs. Mouse hepatitis virus (MHV), a prototypic CoV, causes hepatitis and/or 55 encephalitis depending on the strain. Previous studies have detailed many of the cellular pathways 56 critical for or elicited by MHV infection (1, 2) . Several antiviral mechanisms are induced by MHV 57 infection, but MHV encodes proteins that counter these host processes. For instance, interferons 58 (IFNs), especially type 1 IFNs (IFN-I), are vital to limiting MHV infection in mice (3, 4) , but IFN-59 I production and signaling are inhibited during MHV infection in multiple cell types (5) (6) (7) . MHV 60 also inhibits the functions of downstream IFN-stimulated genes (ISGs). For example, the MHV 61 on November 11, 2019 at EAST CAROLINA UNIV http://jvi.asm.org/ Downloaded from macrodomain, a virally encoded ADP-ribosylhydrolase, reverses cellular ADP-ribosylation by 62 IFN-I-induced poly(ADP-ribose) polymerases (PARPs) that limit viral replication (8, 9) . 63
The aryl hydrocarbon receptor (AhR) is a receptor/transcription factor that has been shown 64 to direct multiple host responses. While initially believed to operate only in the context of the 65 cellular response to toxins, AhR is now recognized as a significant regulator of the host immune 66 response as well. AhR in the cytosol is activated by binding ligands which are exogenous, such as 67 the toxin 2,3,7,8-tetrachlorodibenzodioxin (TCDD), or endogenous, such as cellular metabolites 68 ( Fig. 1 ). This triggers AhR translocation to the nucleus, where AhR complexes with AhR nuclear 69 translocator (ARNT) or other binding partners to induce expression of several different proteins 70 (downstream effectors) responsible for degrading the xenobiotic agent and for limiting potential 71 cellular damage. Upregulated genes include cytochrome P450 enzymes (CYPs) that catabolize the 72 exotoxin, negatively regulating AhR activation by depleting AhR ligands (10). Another inhibitory 73 protein, the AhR repressor (AhRR), is also upregulated and competes with ARNT for AhR 74 dimerization in the nucleus (11) . PARP7, also known as TCDD-inducible PARP (TiPARP), is 75 highly induced by AhR activation as well, indicating a relationship to cellular TiPARP is responsible for mitigating the pathology after TCDD administration to mice at least in 77 part due to feedback inhibition of AhR (12) . 78
In the context of the immune response, endogenous metabolites are likely the primary 79 ligands that drive AhR activation. The prototypical endogenous ligand is kynurenine, a tryptophan 80 catabolite produced by indoleamine 2,3-dioxygenase 1 or 2 (IDO1 or IDO2) in immune cells or 81 tryptophan 2,3-dioxygenase (TDO, encoded by the TDO2 gene) in the liver (13, 14) . IDO1, the 82 best characterized of these enzymes, is induced by inflammatory factors such as TGF, . AhR also activates IDO1 expression and enhances its activity through multiple 84 on November 11, 2019 at EAST CAROLINA UNIV http://jvi.asm.org/ Downloaded from pathways (16), and the resulting IDO1-AhR-IDO1 positive feedback loop prolongs effects of AhR 85 activation (17, 18) . Though kynurenine is believed to be the predominant derivative of tryptophan 86 that drives AhR activation, multiple other degradation products of tryptophan or other 87 biomolecules are synthesized independent of IDO1/2 or TDO or can be sourced from the gut 88 microflora, diet, or even UV-mediated photo-oxidation (19) . Prostaglandins, cAMP, and oxidative 89 species may also activate AhR though with unknown physiologic or pathologic significance (20-90 22) . 91
Many studies have demonstrated that AhR activation during immunostimulation and 92 inflammation generally exerts a immunosuppressive effect via multiple mechanisms (23). AhR 93 activation by chemical agonists has been shown to influence the differentiation (24-28) and 94 cytokine/chemokine production (25, 26, 29-32) of T cells, dendritic cells, and macrophages. AhR 95 has also been shown to bind to and modulate the transcription specificity of NF-B in multiple 96 experimental settings, which could contribute to cytokine modulation (30, (33) (34) (35) . Other studies 97 have shown that AhR activation in immune cells is driven by IDO1, and the resulting IDO1-AhR-98 IDO1 positive feedback loop helps to establish immunotolerance (18, 36, 37) . In contrast, less is 99 known about the role of AhR during virus infection. While previous work has explored pathways 100 affected by AhR activation during in influenza A virus (IAV), herpes simplex virus (HSV), 101 hepatitis C virus (HCV), and Epstein-Barr virus (EBV) infection (38-41), the virological impact 102 of AhR is still largely uncharacterized. Here, we show that CoV replication in macrophages results 103 in AhR activation in an IDO1-independent manner, leading to increased expression of several 104 downstream effectors and to modulation of the cytokine response. We also show that TiPARP, 105 induced by AhR, is a pro-viral factor in CoV-infected cells. We used MHV-A59 because it replicates to higher titers than MHV-JHM in vitro (42). 118
Upregulation of most PARPs, including PARPs 9, 11, 12, and 14, was lost or attenuated in these 119 cell lines during infection, contrasting with the robust PARP upregulation profile seen in MHV-120 A59-infected wild type (WT) BMDMs (Fig. 2C ). Despite the diminished expression of many IFN-121 dependent PARPs, TiPARP was highly upregulated following MHV-A59 infection in all three cell 122 types, suggesting a conserved mechanism of induction. Furthermore, induction of TiPARP in 123 IFNAR -/-BMDMs was conserved after infection with MHV-A59, consistent with previous 124 findings with MHV-JHM ( Fig. 2D ). Although not further studied here, PARP13 was also 125 upregulated in infected IFNAR -/cells. Overall, these results indicate that TiPARP is upregulated 126 by another pathway during infection in the absence of IFN-I signaling. 127
TiPARP knockdown restricts MHV-A59 replication. 128
We previously noted that viral genomic RNA TiPARP, and AhRR (Fig. 1 ). We also analyzed gene expression of AhR itself and of AhR ligand-150 producing enzymes IDO1, IDO2, and TDO as IDO1 gene expression can also be induced by AhR 151 activation. We found that, while CYP1A1, CYP1A2, IDO2, and TDO2 mRNA were undetectable 152 at all time points, CYP1B1, AhRR, TiPARP, IDO1, and AhR mRNA were all upregulated over 153 on November 11, 2019 at EAST CAROLINA UNIV http://jvi.asm.org/ Downloaded from the course of infection ( Fig. 4A ). To determine if this response is conserved in other immune cell 154 types, we quantified transcription of these downstream effectors in bone marrow-derived dendritic 155 cells (BMDCs) ( Fig. 4B ). At both 12 and 22 hpi, CYP1B1, AhRR, TiPARP, IDO1, and AhR were 156 all upregulated in BMDCs, suggesting that AhR activation occurs following MHV-A59 infection 157 in multiple cell types. 158
To determine if our in vitro results could be recapitulated in vivo, we infected C57Bl/6 159 mice with MHV-A59 via intraperitoneal injection ( Fig. 4C) . At 3 and 5 days post infection (dpi), 160 levels of CYP1B1, TiPARP, AhRR, and IDO1 mRNA increased in the livers of infected mice, 161
suggesting that MHV elicited AhR activation. Furthermore, upregulation of these downstream 162 genes paralleled viral replication at 3 and 5 dpi as assessed by measuring viral gRNA levels. In 163 contrast to our results in BMDMs, IDO2 and TDO2 mRNA were detectable in liver samples and 164 modestly increased on 3 dpi. 165
Consistent with the results obtained using infected livers, the level of AhR activation 166 correlated with virus replication in BMDMs as downstream effector mRNA levels were less 167 upregulated when cells were infected at lower MOIs (Fig. 5A ). In addition, UV-inactivated virus 168 infection was unable to induce expression of AhR downstream effectors, indicating that AhR 169 activation during MHV infection is completely dependent on viral replication ( Fig. 5B ). 170
AhR antagonist and agonist treatment modulates expression of downstream effector genes 171 during infection. 172
To examine whether AhR activation and not an alternative factor facilitated expression of 173 these downstream effectors, we infected cells following chemical inhibition of AhR (Fig. 6A ). We 174 opted for treatment with CH-223191, a well-described chemical inhibitor that prevents ligand 175 binding to AhR (Fig. 1 ) but does not inhibit other receptors such as the estrogen receptor (44, 45) . 176 on November 11, 2019 at EAST CAROLINA UNIV http://jvi.asm.org/
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We first confirmed that CH-223191 inhibited chemical AhR activation by agonist TCDD in 177
BMDMs without altering cell viability ( Fig. 6B & C) . During MHV-A59 infection, AhR inhibitor 178 treatment resulted in dose-dependent attenuation of CYP1B1, AhRR, and IDO1. Surprisingly, 179
TiPARP induction was not diminished at any concentration of inhibitor. Furthermore, CH-223191 180 treatment actually increased AhR mRNA levels slightly at 12 hpi but had no effect on gRNA 181 levels, indicating that the CH-223191-mediated reduction in downstream effector expression was 182 due to inhibition of AhR activation itself rather than decreased AhR expression or increased virus 183 replication. 184
To complement these results and to determine if concurrent chemical activation during 185 infection could further activate AhR, we treated BMDMs with TCDD and quantified induction of 186 the same downstream effector genes that were attenuated by AhR inhibition (Fig. 7A ). After 187 confirming that TCDD that did not affect cell viability (Fig. 7B ), we found that agonist treatment 188 TiPARP mRNA levels in IFNAR -/-BMDMs was less than that of CYP1B1, AhRR, or IDO1, 206 suggesting that an additional, as yet unknown, factor modulated its expression. Finally, gRNA 207 levels in IFNAR -/-BMDMs trended toward a modest reduction following AhR inhibition (p=0.12), 208 possibly reflecting decreases in TiPARP expression. Taken together, our data show that MHV-209 induced AhR activation is responsible for upregulation of CYP1B1, AhRR, and IDO1 in IFN-210 replete and -deficient cells and of TiPARP in the absence of IFN-I signaling. 211
MHV infection activates AhR in an IDO1-independent manner. 212
While our results indicated that AhR activation during MHV-A59 infection modulates 213 downstream IDO1 expression ( Fig. 6 to Fig. 8 ), IDO1 can also act as an upstream regulator of 214 AhR by catabolizing tryptophan to the AhR ligand kynurenine (Fig. 1) (13, 17) . To determine if 215 IDO1 has a role in AhR activation during MHV-A59 infection, we infected IDO1 -/-BMDMs with 216 MHV-A59 and quantified effector mRNA levels (Fig. 9B) . Interestingly, levels of CYP1B1, 217
AhRR, TiPARP, AhR, and gRNA were equivalent following infection in WT or IDO1 -/-BMDMs. 218
As expected, IDO1 mRNA was not detectable in deficient cells. To rule out compensatory effects 219 of other enzymes known to produce kynurenine, we also assessed cells for IDO2 and TDO2 mRNA 220 but could detect neither in WT or IDO1 -/-BMDMs. Together, our results suggest that MHV-A59 221 infection of BMDMs elicits AhR activation through a pathway independent of IDO1. infection by chemical means (Fig. 7) , we substantiated these findings by treating BMDMs with 232 TCDD in the presence or absence of infection at low and high MOI (Fig. 10B ). Consistent with 233 our AhR inhibitor data, TNF mRNA was decreased, and IL-1 and IL-10 mRNA were increased 234 by concurrent chemical activation of AhR. In summary, these results indicate that AhR activation 235 modulates multiple cytokine expression levels during MHV-A59 infection. 236
237
Discussion 238
Here, we showed that MHV infection activates AhR, resulting in upregulation of multiple 239 downstream effector genes, including CYP1B1, AhRR, and IDO1, in infected BMDMs, BMDCs, 240 and mouse livers (Fig. 4) . We also demonstrated that another AhR downstream effector, TiPARP, 241 has a pro-viral role on MHV replication as genomic RNA levels and virus titers were decreased 242 following TiPARP knockdown (Fig. 3) . TiPARP induction is a multifactorial manner, since IFN-243 I treatment induced TiPARP expression in BMDMs (8) but TiPARP expression was still observed 244 in cell lines deficient in IFN expression and in IFNAR -/-BMDMs (Fig. 2) . Our results showed that 245 on November 11, 2019 at EAST CAROLINA UNIV http://jvi.asm.org/
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AhR activation directly induces TiPARP expression as TCDD treatment enhanced TiPARP 246 expression in uninfected and to a lesser extent in infected cells (Fig. 6) . Further, TiPARP induction 247 during infection was sensitive to chemical AhR inhibition in the absence but not the presence of 248 IFN-I signaling in WT BMDMs (Fig. 6 and Fig. 8 or TGF signaling pathways could also impact its expression during CoV infection (46) (47) (48) . 253
In addition to decreased replication, TiPARP knockdown also resulted in increased IFN4 254 and IFN mRNA expression ( Fig. 3C ). However, viral genomic RNA levels were reduced in 255
TiPARP knockdown cells as early as 6 hpi, before IFN-I mRNA levels increased. Further study 256 will be required to establish a causal relationship between the effects of TiPARP on IFN-I 257 expression and replication. Our results align with a previous study showing that that TiPARP 258 during IAV infection ADP-ribosylates TBK1, resulting in increased replication and reduced IFN-259 I levels (40). However, TiPARP has also been shown to bind to Sindbis virus RNA to trigger an 260 antiviral host response. Therefore, it will be important to determine whether TiPARP facilitation 261 of MHV replication is dependent on its ADP-ribosylating and/or its RNA-binding activities. 262
In contrast with TiPARP, upregulation of downstream effectors CYP1B1, AhRR, and 263 IDO1 during infection is driven primarily by AhR activation. This is evidenced by the fact that 264 expression of these effectors was enhanced by an AhR agonist and attenuated in a dose-dependent 265 manner by an AhR-specific inhibitor (Fig. 6 and Fig. 7) . While AhR activation has been studied 266 in immune cells following treatment following agonist or immunostimulants treatment, its role in our results demonstrate that MHV infection activates AhR independent of IDO1 ( Fig. 1 & 9) . We 279 detected gene expression of IDO2 and TDO2 in infected murine liver samples (Fig. 4C) , consistent 280 with the notion that TDO is largely constrained to the liver (14). While TDO or IDO2 could be 281 driving AhR activation by producing kynurenine during in vivo infection, IDO2 and TDO mRNA 282 were undetectable in in IDO1 -/-BMDMs. This suggests that kynurenine is produced by a novel 283 IDOI/IDO2/TDO-independent pathway in BMDMs or that these cells do not utilize kynurenine as 284 the primary AhR ligand during CoV infection. AhR can be activated by several biochemical 285 species, including metabolites of tryptophan or bilirubin or other metabolites of uncharacterized 286 biosynthetic pathways (49-52). Other potential initiating pathways include prostaglandin 287 synthesis, cAMP production, or general oxidative stress (20) (21) (22) . Alternatively, a host or viral 288 protein during infection could directly bind to AhR, enhancing its transactivation activity in a 289 manner similar to that of EBV-encoded EBNA-3, though this may still require concomitant ligand 290 binding (41). Nonetheless, the levels of the ligand or binding partner activating AhR in BMDMs 291 on November 11, 2019 at EAST CAROLINA UNIV http://jvi.asm.org/ Downloaded from would likely scale with replication as downstream effector transcription correlated with virus load 292 ( Fig. 5) . Additional investigation will be necessary to detail the exact mechanism of this IDO-293 independent AhR activation pathway. Furthermore, while IDO1 does not regulate AhR activation 294 during MHV infection in BMDMs, it could still be modulating other cellular pathways as part of 295 the host response. For instance, IDO1 has been shown to regulate immune cell function by 296 mediating tryptophan starvation, resulting in activation of mTOR, a mediator of several metabolic 297 and immune pathways (53, 54) . 298
Finally, chemical activation or inhibition of AhR during infection resulted in changes in 299 the mRNA levels of multiple cytokines (Fig. 10 ), suggesting that AhR functions to modulate the 300 cytokine response to MHV infection. Specifically, AhR negatively regulated TNF and 301 positively regulated IL-1 and IL-10, cytokines which are also upregulated in the brains of 302 MHV-infected mice (2). These changes were not due to alterations in viral replication, as viral 303 load was unchanged by AhR activation or inhibition. The mechanism driving cytokine changes 304 during MHV infection is likely complex but probably involves interaction of activated AhR with 305 NF-B (30, 33-35, 55) (Fig. 1) . The effects of these cytokine expression changes will need to be 306 investigated in vivo to determine their role in pathogenesis because their functions are protean 307 because some of these cytokines are additionally post-transcriptionally regulated, and because 308 activating ligands may differ in cultured BMDMs versus infected mice. Thus, it is difficult to 309 conclude at present that AhR drives a strictly pro-or anti-inflammatory phenotype. Rather, AhR 310 activation may serve to fine tune the innate immune response to MHV infection. Roswell Park Memorial Institute (RPMI) media for 7-8 days. BMDMs were washed and replaced 326 with fresh media every day after the 4th day. Bone marrow cells obtained from WT C57BL/6 mice 327 were differentiated into dendritic cells (BMDCs) by incubating cells with 50 g/ml 328 granulocyte/macrophage colony stimulating factor (GM-CSF) and 20 g/ml IL-4. Extra media was 329 added at day 3 to refresh the cells, media was fully changed on day 6, and cells were used for 330 infections on day 7. 331 Virus infection. Mouse hepatitis virus (MHV) strain A59 (MHV-A59) (56) was 332 propagated on 17Cl-1 cells in the same manner as described previously (8) 
